Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1Dermatologic 1

Conditions

Breast Neoplasms 38Neoplasms 33Depression 28Fatigue 24Prostatic Neoplasms 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Large B-Cell, Diffuse 17Lymphoma, Follicular 17Multiple Myeloma 15Lymphoma, Non-Hodgkin 14Lymphoma, Mantle-Cell 14Leukemia, Lymphocytic, Chronic, B-Cell 14Burkitt Lymphoma 14Lymphoma, B-Cell, Marginal Zone 13Leukemia, Myeloid, Acute 13Hodgkin Disease 13Colorectal Neoplasms 13Lymphoma, Large-Cell, Immunoblastic 12Lung Neoplasms 12Anxiety Disorders 12Lymphoma 11Leukemia, Myeloid, Chronic-Phase 11Blast Crisis 11Leukemia, Myeloid, Accelerated Phase 10Recurrence 9Pain 9Lymphoma, T-Cell, Cutaneous 9Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9Leukemia, Hairy Cell 9Leukemia 9

Interventions

Cisplatin 21pembrolizumab 16Gemcitabine 16Paclitaxel 15Radiotherapy 14Carboplatin 14Radiotherapy, Intensity-Modulated 13Cyclophosphamide 9Cetuximab 9Magnetic Resonance Spectroscopy 8Radiation 7padeliporfin 6Specimen Handling 6Oxaliplatin 6Fluorouracil 6Drug Therapy 6Docetaxel 6Capecitabine 6Bevacizumab 6anlotinib 5Nivolumab 5Irinotecan 5Erlotinib Hydrochloride 5Celecoxib 5poly ICLC 4fludarabine 4Standard of Care 4Sorafenib 4Leucovorin 4Ipilimumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Carcinoma × Therapeutics × Clear all
NCT05845632 2023-08-16

Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma

Maastricht University Medical Center

Unknown
965 enrolled
DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Squamous Cell, Neoplasm Metastasis, Recurrence, Skin Neoplasms

NCT00975429 2015-04-28

Study Using WST11 in Patients With Localized Prostate Cancer

Steba Biotech S.A.

Phase 2 Completed
86 enrolled
Genitourinary

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡